Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Gestational Diabetes: Screening

About this resource:

Systematic Review

Source: U.S. Preventive Services Task Force

Last Reviewed: August 2021

Workgroups: Diabetes Workgroup, Maternal, Infant, and Child Health Workgroup

The U.S. Preventive Services Task Force (USPSTF) recommends screening for gestational diabetes at or after 24 weeks of pregnancy. This recommendation applies to pregnant women who haven't been diagnosed with type 1 or type 2 diabetes and who don't have symptoms of gestational diabetes. USPSTF found insufficient evidence to assess whether the benefits of gestational diabetes screening before 24 weeks of pregnancy outweigh the harms.

Read more about this resource

Objectives related to this resource (3)

Reduce the number of diabetes cases diagnosed yearly — D‑01
LHI label
Baseline only
Increase the proportion of pregnant women who receive early and adequate prenatal care — MICH‑08
Getting worse
Increase the proportion of women who had a healthy weight before pregnancy — MICH‑13
Getting worse

Suggested Citation

1.

U.S. Preventive Services Task Force. (2021). Final update summary: Gestational Diabetes: Screening. Retrieved from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/gestational-diabetes-screening